Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs945194 | chr6:150386262 | T/C | 9.71E-7 | 171 | 1.83 | 24.53 | 25.97 | KM Plot |
PCPG | rs9497698 | chr6:147416176 | A/T | 0.000259 | 178 | 25.47 | 26.62 | 8.67 | KM Plot |
PCPG | rs950318 | chr3:80403186 | C/G | 4.66E-7 | 176 | 25.77 | 23.53 | 19.87 | KM Plot |
PCPG | rs9507917 | chr13:28238930 | C/G | 5.84E-6 | 177 | 25.28 | 26.57 | 11.78 | KM Plot |
PCPG | rs9512781 | chr13:28241123 | C/T | 5.38E-6 | 178 | 11.78 | 26.57 | 25.17 | KM Plot |
PCPG | rs9513224 | chr13:97935785 | A/G | 0.000322 | 178 | 20.13 | 26.27 | 25.4 | KM Plot |
PCPG | rs951367 | chr3:182474060 | C/T | 1.19E-5 | 174 | 13.27 | 25.85 | 25.53 | KM Plot |
PCPG | rs951978 | chr3:80578514 | G/C | 6.99E-5 | 176 | 19.53 | 24.53 | 27.2 | KM Plot |
PCPG | rs951979 | chr3:80578398 | G/C | 6.99E-5 | 176 | 19.53 | 24.53 | 27.2 | KM Plot |
PCPG | rs9528656 | chr13:64106538 | T/C | 2.74E-5 | 178 | 22.63 | 22.63 | 26.57 | KM Plot |
PCPG | rs9528657 | chr13:64107535 | A/C | 2.74E-5 | 178 | 22.63 | 22.63 | 26.57 | KM Plot |
PCPG | rs9531998 | chr13:37525567 | T/C | 0.000329 | 176 | 4.17 | 24.23 | 25.7 | KM Plot |
PCPG | rs9532001 | chr13:37535810 | T/C | 0.00031 | 177 | 4.17 | 24.23 | 25.87 | KM Plot |
PCPG | rs9532002 | chr13:37545515 | A/G | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs9532005 | chr13:37588854 | G/A | 0.000285 | 178 | 4.17 | 24.7 | 25.7 | KM Plot |